id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dhrp-31	Rao, Sohail; White, Caitlin; Singh, Manish	Is There Any Advantage of Using Polyclonal vs. Monoclonal Antibodies for Passive Enhancement of Immunity in Patients with COVID-19?	2021	3	.pdf	application/pdf	1218	67	32	Produced in vitro from immortalized plasma cells, monoclonal antibodies have single specificity and affinity which, reduces the probability of cross reactivity (Figure 1). Due to batch-to-batch homogeneity, effectiveness of monoclonal antibodies is much more predictable, and they serve as an ideal candidate for use in diagnostic immunoassays.	cache/dhrp-31.pdf	txt/dhrp-31.txt
